NRXP NRx Pharmaceuticals, Inc.

NASDAQ
$2.15

NRx Pharmaceuticals, Inc. (NRXP) Earnings News

Earnings press releases, previews and reviews for NRx Pharmaceuticals, Inc. (NRXP), newest first. Our most recent is review: NRx Pharmaceuticals Beats on EPS as First FDA Approval Arrives, but Operating Losses and Slipping Timelines Undercut the Headline.